Crystal structure analysis of anti-V2 mAb 2158 suggests a conformational epitope involving an N-linked glycan

Crystal structure analysis of anti-V2 mAb 2158 suggests a conformational epitope involving an N-linked glycan

Bibliographic Details
Main Authors:	Spurrier B, Pan R, Sampson J, Williams C, Gorny M, Zolla-Pazner S, Kong X
Format:	Article
Language:	English
Published:	BMC 2012-09-01
Series:	Retrovirology

Similar Items

High-resolution crystal structure of the Fv of quaternary neutralizing epitope mAb 2909 reveals atomic details of its antigen-binding site
by: Sampson JM, et al.
Published: (2012-09-01)

Biophysical dissection of the antigen-antibody interaction of the broadly reactive anti-V3 human mAb 447-52D
by: Killikelly A, et al.
Published: (2012-09-01)

Epitope mapping of conformational V2-specific anti-HIV human monoclonal antibodies reveals an immunodominant site in V2.
by: Luzia M Mayr, et al.
Published: (2013-01-01)

Existence of natural mouse IgG mAbs recognising epitopes shared by malondialdehyde acetaldehyde adducts and
by: Mikael Kyrklund, et al.
Published: (2021-02-01)

Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs.
by: Marnie L Fusco, et al.
Published: (2015-06-01)

The functional and structural analysis of integrin B|1 by mapping the epitopes of stimulatory mAbs of integrin B|1
by: Li, Anli
Published: (2007)

The functional and structural analysis of integrin [beta]1 by mapping the epitopes of stimulatory mAbs of integrin [beta]1
by: Li, Anli
Published: (2007)

The functional and structural analysis of integrin [beta]1 by mapping the epitopes of stimulatory mAbs of integrin [beta]1
by: Li, Anli
Published: (2007)

A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes
by: Tal Noy-Porat, et al.
Published: (2020-08-01)

Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope
by: Watanabe, Satoru, et al.
Published: (2018)

The Different Colors of mAbs in Solution
by: Alexandre Ambrogelly
Published: (2021-05-01)

P20-09. Worldwide epitope prevalence of crystallographically resolved anti-V3 antibodies
by: Cardozo TJ, et al.
Published: (2009-10-01)

Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs.
by: Marnie L Fusco, et al.
Published: (2015-10-01)

How Far is the Spanish Snack Sector from Meeting the Acrylamide Regulation 2017/2158?
by: Marta Mesias, et al.
Published: (2020-02-01)

Structural analyses of antigen binding similarities and differences between rabbit and human anti-gp120 V3 mAbs
by: Pan R, et al.
Published: (2012-09-01)

Developments and Challenges for mAb-Based Therapeutics
by: Satoshi Ohtake, et al.
Published: (2013-08-01)

Immunoprophylaxis against mother-to-child transmission of HIV-1.
by: Miroslaw K Gorny, et al.
Published: (2006-07-01)

Short constrained peptides derived from phage display libraries as epitope models: the case of mAb 2F5
by: Palacios-Rodriguez Y, et al.
Published: (2012-09-01)

Comparative magnitude of cross-strain conservation of HIV variable loop neutralization epitopes.
by: James Swetnam, et al.
Published: (2010-12-01)

Biopurification of monoclonal antibody (mAb) through crystallisation
by: Chen, WQ, et al.
Published: (2021)

Determination of critical epitope of PcMab-47 against human podocalyxin
by: Shunsuke Itai, et al.
Published: (2018-07-01)

Rapid identification of anti-idiotypic mAbs with high affinity and diverse epitopes by rabbit single B-cell sorting-culture and cloning technology.
by: WeiYu Lin, et al.
Published: (2020-01-01)

Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans
by: Felix Broecker, et al.
Published: (2016-04-01)

Transforming epitope-specific gp120 monomer-based probes into immunogens with N-linked glycan masking
by: Chuang G, et al.
Published: (2012-09-01)

Assessing social and economic impact of subcutaneous mAbs in oncology
by: Americo Cicchetti, et al.
Published: (2018-05-01)

Studies on CD40mAb-adjuvanted conjugate vaccines
by: Sultana, Tessabelle
Published: (2014)

Dissecting the conformation of glycans and their interactions with proteins
by: Sheng-Hung Wang, et al.
Published: (2020-09-01)

LpMab-12 Established by CasMab Technology Specifically Detects Sialylated O-Glycan on Thr52 of Platelet Aggregation-Stimulating Domain of Human Podoplanin.
by: Yukinari Kato, et al.
Published: (2016-01-01)

Indirect detection of an epitope-specific response to HIV-1 gp120 immunization in human subjects.
by: Evgeny Shmelkov, et al.
Published: (2011-01-01)

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope
by: Wang S, et al.
Published: (2009-10-01)

The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs
by: Josée Golay, et al.
Published: (2020-10-01)

Restricted N-glycan conformational space in the PDB and its implication in glycan structure modeling.
by: Sunhwan Jo, et al.
Published: (2013-01-01)

Conformational Heterogeneity of the HIV Envelope Glycan Shield
by: Mingjun Yang, et al.
Published: (2017-06-01)

Epitope mapping of an anti-diacylglycerol kinase delta monoclonal antibody DdMab-1
by: Masato Sano, et al.
Published: (2020-12-01)

Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb.
by: Vincent Boudousq, et al.
Published: (2013-01-01)

Endoplasmic reticulum retention motif fused to recombinant anti-cancer monoclonal antibody (mAb) CO17-1A affects mAb expression and plant stress response.
by: Ilchan Song, et al.
Published: (2018-01-01)

Preparation of a hetero-divalent glycan epitope for cancer vaccine development
by: Li-Ju Huang, et al.
Published: (2018)

Terminal Epitope-Dependent Branch Preference of Siglecs Toward N-Glycans
by: Shuaishuai Wang, et al.
Published: (2021-04-01)

Residue 315 regulates V3 exposure and V3 antibody recognition on HIV subtype B and C viruses
by: Manhas S, et al.
Published: (2012-09-01)

Comparative efficacy and safety of chimeric and recombinant anti-TNF-α mAbs
by: V. N. Drozdov, et al.
Published: (2021-05-01)